口服米诺地尔在斑秃治疗中的应用

doi:10.35541/cjd.20240626

中华皮肤科杂志 ›› 2025, Vol. 58 ›› Issue (7): 653-656.doi: 10.35541/cjd.20240626

口服米诺地尔在斑秃治疗中的应用

王琴¹ 林尽染¹ 刘庆梅¹ 吴文育^1，2，3

¹复旦大学附属华山医院皮肤科，上海市皮肤病研究所，上海 200040；²上海市静安区中心医院皮肤科，上海 200040；³复旦大学工程与应用技术研究院，上海 200433

收稿日期:2024-11-15 修回日期:2025-04-08 发布日期:2025-07-03
通讯作者: 吴文育 E-mail:wenyu_wu@fudan.edu.cn
基金资助:
上海市卫生健康领军人才项目（2022LJ017）；上海申康医院发展中心项目（SHDC22022302）；上海市重中之重研究中心建设项目（2023ZZ02018）；上海市临床重点专科（shslczdzk01002）；上海毛发医学工程技术研究中心项目（19DZ2250500）；静安区学科建设项目培育学科（2024PY01）

Oral minoxidil in the treatment of alopecia areata

Wang Qin¹, Lin Jinran¹, Liu Qingmei¹, Wu Wenyu^1,2,3

¹Department of Dermatology,Huashan Hospital,Shanghai Institute of Dermatology,Fudan University, Shanghai 200040, China; ²Department of Dermatology, Jing'an District Central Hospital, Shanghai 200040, China; ³Academy for Engineering and Technology, Fudan University, Shanghai 200433, China

Received:2024-11-15 Revised:2025-04-08 Published:2025-07-03
Contact: Wu Wenyu E-mail:wenyu_wu@fudan.edu.cn
Supported by:
Leading Talent Project of Shanghai Health Commission （2022LJ017）; Clinical Research Plan of Shanghai Hospital Development Center Foundation （SHDC22022302）; Key Specialty Research Centre of Shanghai Health Commission（2023ZZ02018）; Shanghai Municipal Key Clinical Specialty （shslczdzk01002）; Shanghai Engineering Research Center of Hair Medicine （19DZ2250500）; Jing'an District Discipline Development Education Program （2024PY01）

摘要/Abstract

摘要： 【摘要】口服米诺地尔已被用于治疗各种脱发性疾病，包括斑秃，但单用米诺地尔疗效尚不清楚。近年来，口服米诺地尔开始作为Janus激酶抑制剂等药物的辅助用药应用于斑秃的治疗。本文综述口服米诺地尔在斑秃治疗中的应用。

关键词: 斑秃, 米诺地尔, 口服给药, 治疗, 有效性, 安全性

Abstract: 【Abstract】 Oral minoxidil has been used to treat various hair loss disorders, including alopecia areata, though its efficacy as a monotherapy remains unclear. In recent years, oral minoxidil has increasingly been applied as an adjuvant treatment alongside other agents such as Janus kinase inhibitors for alopecia areata. This review summarizes the current application of oral minoxidil in the treatment of alopecia areata.

Key words: Alopecia areata, Minoxidil, Oral administration, Therapy, Efficacy, Safety

王琴林尽染刘庆梅吴文育. 口服米诺地尔在斑秃治疗中的应用[J]. 中华皮肤科杂志, 2025,58(7):653-656. doi:10.35541/cjd.20240626

Wang Qin, Lin Jinran, Liu Qingmei, Wu Wenyu, . Oral minoxidil in the treatment of alopecia areata[J]. Chinese Journal of Dermatology, 2025, 58(7): 653-656.doi:10.35541/cjd.20240626

参考文献 31

［1］	Dainichi T, Iwata M, Kaku Y. Alopecia areata: what's new in the epidemiology, comorbidities, and pathogenesis?［J］. J Dermatol Sci, 2023,112（3）:120⁃127. doi: 10.1016/j.jdermsci.2023.09.008.
［2］	Waśkiel⁃Burnat A, Kołodziejak M, Sikora M, et al. Therapeutic management in paediatric alopecia areata: a systematic review［J］. J Eur Acad Dermatol Venereol, 2021,35（6）:1299⁃1308. doi: 10.1111/jdv.17187.
［3］	丁雨薇, 乔建军, 方红. 小分子靶向药物和生物制剂治疗斑秃的研究进展［J］. 中华皮肤科杂志, 2022,55（12）:1118⁃1121. doi: 10.35541/cjd.20200563.
［4］	Nakamura K, Kamei K, Austin J, et al. Degree of alignment between Japanese patients and physicians on alopecia areata disease severity and treatment satisfaction: a real⁃world survey［J］. Dermatol Ther （Heidelb）, 2024,14（1）:151⁃167. doi: 10. 1007/s13555⁃023⁃01067⁃y.
［5］	King BA, Craiglow BG. Janus kinase inhibitors for alopecia areata［J］. J Am Acad Dermatol, 2023,89（2S）:S29⁃S32. doi: 10.1016/j.jaad.2023.05.049.
［6］	Wei D, Chen Y, Shen Y, et al. Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta⁃analysis［J］. Front Immunol, 2023,14:1152513. doi: 10.3389/fimmu.2023.1152513.
［7］	Heymann WR. Coming full circle （almost）: low dose oral minoxidil for alopecia［J］. J Am Acad Dermatol, 2021,84（3）:613⁃614. doi: 10.1016/j.jaad.2020.12.053.
［8］	Fiedler⁃Weiss VC, Rumsfield J, Buys CM, et al. Evaluation of oral minoxidil in the treatment of alopecia areata［J］. Arch Dermatol, 1987,123（11）:1488⁃1490.
［9］	Fiedler VC, Buys CM. Direct T⁃cell effects of minoxidil［J］. Clin Dermatol, 1988,6（4）:148⁃151. doi: 10.1016/0738⁃081x（88）90079⁃x.
［10］	Rudnicka L, Arenbergerova M, Grimalt R, et al. European expert consensus statement on the systemic treatment of alopecia areata［J］. J Eur Acad Dermatol Venereol, 2024,38（4）:687⁃694. doi: 10.1111/jdv.19768.
［11］	Moussa A, Eisman S, Kazmi A, et al. Treatment of moderate⁃to⁃severe alopecia areata in adolescents with baricitinib: a retrospective review of 29 patients［J］. J Am Acad Dermatol, 2023,88（5）:1194⁃1196. doi: 10.1016/j.jaad.2022.12.033.
［12］	Valido K, Craiglow BG. Baricitinib and oral minoxidil for the treatment of alopecia areata in pediatric patients［J］. J Am Acad Dermatol, 2025:S0190⁃9622（25）00565⁃00561. doi: 10.1016/j.jaad.2025.03.085.
［13］	Jerjen R, Meah N, Trindade de Carvalho L, et al. Treatment of alopecia areata in pre⁃adolescent children with oral tofacitinib: a retrospective study［J］. Pediatr Dermatol, 2021,38（1）:103⁃108. doi: 10.1111/pde.14422.
［14］	Sanchez⁃Diaz M, Diaz⁃Calvillo P, Rodriguez⁃Pozo JA, et al. Tofacitinib for treatment of alopecia areata: real⁃world evidence and factors associated with therapeutic response［J］. Acta Derm Venereol, 2022,102:adv00736. doi: 10.2340/actadv.v102.2036.
［15］	Wambier CG, Craiglow BG, King BA. Combination tofacitinib and oral minoxidil treatment for severe alopecia areata［J］. J Am Acad Dermatol, 2021,85（3）:743⁃745. doi: 10.1016/j.jaad.2019. 08.080.
［16］	Moussa A, Bokhari L, Sinclair RD. Systemic minoxidil as maintenance treatment in alopecia areata: a retrospective case series of 24 patients［J］. Clin Exp Dermatol, 2022,47（4）:753⁃755. doi: 10.1111/ced.15051.
［17］	Vañó⁃Galván S, Pirmez R, Hermosa⁃Gelbard A, et al. Safety of low⁃dose oral minoxidil for hair loss: a multicenter study of 1404 patients［J］. J Am Acad Dermatol, 2021,84（6）:1644⁃1651. doi: 10.1016/j.jaad.2021.02.054.
［18］	Darchini⁃Maragheh E, Rees H, Moussa A, et al. Role of systemic minoxidil in the treatment of alopecia areata: a scoping review to direct future research［J］. J Am Acad Dermatol, 2024,90（6）:1304⁃1306. doi: 10.1016/j.jaad.2024.02.031.
［19］	Jimenez⁃Cauhe J, Saceda⁃Corralo D, Rodrigues⁃Barata R, et al. Characterization and management of hypertrichosis induced by low⁃dose oral minoxidil in the treatment of hair loss［J］. J Am Acad Dermatol, 2021,84（1）:222⁃223. doi: 10.1016/j.jaad. 2020.08.124.
［20］	Moussa A, Kazmi A, Bokhari L, et al. Bicalutamide improves minoxidil⁃induced hypertrichosis in female pattern hair loss: a retrospective review of 35 patients［J］. J Am Acad Dermatol, 2022,87（2）:488⁃490. doi: 10.1016/j.jaad.2021.10.048.
［21］	Nohria A, Desai D, Sikora M, et al. To evaluate hypertrichosis with low dose oral minoxidil and spironolactone combination therapy for alopecia［J］. Arch Dermatol Res, 2024,316（8）:510. doi: 10.1007/s00403⁃024⁃03261⁃0.
［22］	Ong M, Do H, Ho B, et al. Low⁃dose oral minoxidil for androgenetic alopecia is not associated with clinically significant blood⁃pressure changes: a retrospective study［J］. J Am Acad Dermatol, 2024,90（2）:425⁃427. doi: 10.1016/j.jaad.2023.10.010.
［23］	Sanabria BD, Palmegiani E, Seron AF, et al. Prospective cardiovascular evaluation with 24⁃hour Holter and 24⁃hour ambulatory blood pressure monitoring in men using 5⁃mg oral minoxidil for androgenetic alopecia［J］. J Am Acad Dermatol, 2023,88（2）:436⁃437. doi: 10.1016/j.jaad.2022.05.026.
［24］	Jimenez⁃Cauhe J, Pirmez R, Müller⁃Ramos P, et al. Safety of low⁃dose oral minoxidil in patients with hypertension and arrhythmia: a multicenter study of 264 patients［J］. Actas Dermosifiliogr, 2024,115（1）:28⁃35. doi: 10.1016/j.ad.2023.07.019.
［25］	John JM, Sinclair R. Safety and tolerability of low⁃dose oral minoxidil in adolescents: a retrospective review［J］. J Am Acad Dermatol, 2023,88（2）:502⁃504. doi: 10.1016/j.jaad.2022.06. 1195.
［26］	Sánchez⁃Díaz M, López⁃Delgado D, Montero⁃Vílchez T, et al. Systemic minoxidil accidental exposure in a paediatric population: a case series study of cutaneous and systemic side effects［J］. J Clin Med, 2021,10（18）:4257. doi: 10.3390/jcm 10184257.
［27］	Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth［J］. Br J Dermatol, 2004,150（2）:186⁃194. doi: 10. 1111/j.1365⁃2133.2004.05785.x.
［28］	Lachgar S, Charveron M, Gall Y, et al. Minoxidil upregulates the expression of vascular endothelial growth factor in human hair dermal papilla cells［J］. Br J Dermatol, 1998,138（3）:407⁃411. doi: 10.1046/j.1365⁃2133.1998.02115.x.
［29］	Fiedler VC, Buys CM. Immunohistochemical characterization of the cellular infiltrate in severe alopecia areata before and after minoxidil treatment［J］. Dermatologica, 1987,175（Suppl 2）:29⁃35. doi: 10.1159/000248899.
［30］	Fiedler⁃Weiss VC, Buys CM. Response to minoxidil in severe alopecia areata correlates with T lymphocyte stimulation［J］. Br J Dermatol, 1987,117（6）:759⁃763. doi: 10.1111/j.1365⁃2133. 1987.tb07357.x.
［31］	Raval RS, Nohria A, Desai D, et al. The use of minoxidil in the treatment of alopecia areata: a systematic review［J］. J Am Acad Dermatol, 2024,91（3）:508⁃509. doi: 10.1016/j.jaad.2024.05.037.

[1]	张莉宋秀祖. 血管内皮生长因子在雄激素性秃发中的研究进展[J]. 中华皮肤科杂志, 2025, 58(7): 683-685.
[2]	邵光辉李煜乾陈启韬朱麒麟朱晶李中明杜旭峰范卫新. 先天性三角形秃发研究进展[J]. 中华皮肤科杂志, 2025, 58(7): 668-671.
[3]	王琴倪春雅杨凯林尽染吴文育. 口服低剂量米诺地尔在雄激素性秃发治疗中的应用[J]. 中华皮肤科杂志, 2025, 58(7): 657-660.
[4]	魏然李钦峰. 儿童斑秃新型靶向药物治疗研究进展[J]. 中华皮肤科杂志, 2025, 58(7): 650-653.
[5]	林尽染梁晓进刘庆梅吴文育. 雄激素性秃发与代谢综合征的关联：从发病机制到治疗策略[J]. 中华皮肤科杂志, 2025, 58(7): 591-594.
[6]	吕书影王英林文君杨顶权. 联合托法替布治疗21例匐行性斑秃回顾性分析[J]. 中华皮肤科杂志, 2025, 58(7): 630-635.
[7]	中华医学会皮肤性病学分会毛发学组. 毛发扁平苔藓/前额纤维化性秃发诊疗中国专家共识（2025版）[J]. 中华皮肤科杂志, 2025, 58(7): 583-590.
[8]	孙佳怡宋秀祖. 自噬在毛发生理病理中的研究进展[J]. 中华皮肤科杂志, 2025, 58(7): 679-682.
[9]	李翔倩张建中周城. 系统小分子药物和生物制剂治疗斑秃的临床研究进展[J]. 中华皮肤科杂志, 2025, 58(7): 646-649.
[10]	中华医学会皮肤性病学分会中国医师协会皮肤科医师分会. 中国难治性慢性自发性荨麻疹诊治指南（2025版）[J]. 中华皮肤科杂志, 2025, 58(6): 485-496.
[11]	黄雪薇陈奇权杨显杰陈安祺王欢邓思思翟志芳王娟宋志强. 荨麻疹性血管炎与伴色素沉着慢性自发性荨麻疹的临床与病理特征对比分析[J]. 中华皮肤科杂志, 2025, 58(6): 508-514.
[12]	赵美茹肖萌张新美张俊艳亓玉青王惠平. 奥马珠单抗治疗妊娠期或哺乳期慢性自发性荨麻疹患者8例临床分析[J]. 中华皮肤科杂志, 2025, 58(6): 536-539.
[13]	邱里肖汀. 布鲁顿酪氨酸激酶抑制剂在慢性自发性荨麻疹治疗中的进展[J]. 中华皮肤科杂志, 2025, 58(6): 563-567.
[14]	于金蕾吴桥芳孙悦鑫包军周映. 佩索利单抗治疗6例泛发性脓疱型银屑病临床观察[J]. 中华皮肤科杂志, 2025, 0(5): 20240440-e20240440.
[15]	白璐楚妍刘园园朱才勇. 慢性手部湿疹的治疗进展[J]. 中华皮肤科杂志, 2025, 58(5): 477-480.

口服米诺地尔在斑秃治疗中的应用

Oral minoxidil in the treatment of alopecia areata

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 31

相关文章 15

Metrics

本文评价

推荐阅读 10